FMED vs. FSMEX
FMED (Fidelity Disruptive Medicine ETF) and FSMEX (Fidelity Select Medical Technology and Devices Portfolio) are both Health & Biotech Equities funds from Fidelity. Over the past 3 years, FMED returned 1.97%/yr vs 0.66%/yr for FSMEX. Their correlation of 0.83 suggests significant overlap in exposure. FMED charges 0.50%/yr vs 0.68%/yr for FSMEX.
Performance
FMED vs. FSMEX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FMED achieves a -2.44% return, which is significantly higher than FSMEX's -17.04% return.
FMED
- 1D
- 1.03%
- 1M
- 6.62%
- YTD
- -2.44%
- 6M
- -4.06%
- 1Y
- 12.97%
- 3Y*
- 1.97%
- 5Y*
- —
- 10Y*
- —
FSMEX
- 1D
- -1.02%
- 1M
- 2.23%
- YTD
- -17.04%
- 6M
- -17.34%
- 1Y
- -10.67%
- 3Y*
- 0.66%
- 5Y*
- -2.51%
- 10Y*
- 9.59%
FMED vs. FSMEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | -2.44% | 9.69% | 2.29% | -3.59% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | -17.04% | 8.13% | 18.37% | -2.21% |
Correlation
The correlation between FMED and FSMEX is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.78 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.83 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2023 | 0.83 |
The correlation between FMED and FSMEX has been stable across timeframes, ranging from 0.78 to 0.83 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FMED vs. FSMEX — Risk / Return Rank
FMED
FSMEX
FMED vs. FSMEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FMED | FSMEX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.23 | ||
| Sortino ratioReturn per unit of downside risk | +1.79 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 0.92 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 0.71 | -0.39 | +1.10 |
| Martin ratioReturn relative to average drawdown | 1.55 | -0.88 | +2.43 |
Loading charts...
Drawdowns
FMED vs. FSMEX - Drawdown Comparison
The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum FSMEX drawdown of -40.34%. Use the drawdown chart below to compare losses from any high point for FMED and FSMEX.
Loading charts...
Drawdown Indicators
| FMED | FSMEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -21.84% | -40.34% | +18.50% |
Max Drawdown (1Y)Largest decline over 1 year | -18.33% | -26.28% | +7.95% |
Max Drawdown (3Y)Largest decline over 3 years | -21.84% | -26.28% | +4.44% |
Max Drawdown (5Y)Largest decline over 5 years | — | -40.34% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -40.34% | — |
Current DrawdownCurrent decline from peak | -8.48% | -22.31% | +13.83% |
Average DrawdownAverage peak-to-trough decline | -7.11% | -7.78% | +0.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.38% | 11.70% | -3.32% |
Volatility
FMED vs. FSMEX - Volatility Comparison
The current volatility for Fidelity Disruptive Medicine ETF (FMED) is 6.57%, while Fidelity Select Medical Technology and Devices Portfolio (FSMEX) has a volatility of 7.23%. This indicates that FMED experiences smaller price fluctuations and is considered to be less risky than FSMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FMED | FSMEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.57% | 7.23% | -0.66% |
Volatility (6M)Calculated over the trailing 6-month period | 15.04% | 15.26% | -0.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.27% | 18.81% | +0.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.53% | 21.10% | -2.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.53% | 20.81% | -2.28% |
FMED vs. FSMEX - Expense Ratio Comparison
FMED has a 0.50% expense ratio, which is lower than FSMEX's 0.68% expense ratio.
Dividends
FMED vs. FSMEX - Dividend Comparison
FMED has not paid dividends to shareholders, while FSMEX's dividend yield for the trailing twelve months is around 21.88%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 21.88% | 10.53% | 17.04% | 0.00% | 1.80% | 8.12% | 6.65% | 1.77% | 7.47% | 6.26% | 5.84% | 16.35% |
Frequently Asked Questions
FMED and FSMEX have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FSMEX has higher volatility (7.23%) compared to FMED (6.57%). In terms of maximum drawdown, FMED dropped -21.84% vs FSMEX's -40.34%.
FMED currently has the higher Sharpe Ratio (0.68 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FMED and FSMEX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer